TY  - JOUR

T1  - Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: An updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG

JO  - Journal of Bone Oncology

UR  - https://doi.org/10.1016/j.jbo.2025.100694

PY  - 2025/06/01

AU  - Hadji P

AU  - Aapro M

AU  - Al-Dagri N

AU  - Alokail M

AU  - Biver E

AU  - Body J-J

AU  - Brandi ML

AU  - Brown J

AU  - Confavreux C

AU  - Cortet B

AU  - Drake M et al

ED  - 

DO  - DOI: 10.1016/j.jbo.2025.100694

PB  - Elsevier BV

SP  - 100694

EP  - 100694

Y2  - 2025/06/18

ER  -